Back to Journals » Journal of Hepatocellular Carcinoma » Volume 5

Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)

Total article views   Abstract views HTML views PDF downloads Totals
2,704 Dovepress* 1,905 547+ 570 2,452
PubMed Central* 0 252 64 252
Totals 1,905 799 634 2,704
*Since 19 November 2018
+Since July 2016

View citations on PubMed Central and Google Scholar